CDT Equity Inc. (CDT) investor relations documents from the company's IR site: 1 presentation; latest deck 2026-04-28. Read in-app with summaries. First-party data.
Corporate Presentation: CDT Equity Inc. is a biopharmaceutical company utilizing Agentic AI and cocrystallization to develop and out-license assets, including three licensed from AstraZeneca.
| Published | Type | Document |
|---|---|---|
| 2026-04-28 | Presentation | Corporate Presentation |
CDT overview · CDT earnings · CDT financials · CDT KPIs · CDT ownership · CDT peers · CDT filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.